In addition, in rats with post-MI heart failure, a combination of canrenone, the active metabolite of potassium canrenoate and ramipril, angiotensin-converting enzyme (ACE) inhibitor, attenuated LV dilation and interstitial remodeling and improved cardiac function compared solo-treatment (Cittadini et al., 2003). Here, ACE is linked to heart failure.